CurifyLabs, a leading healthcare technology company providing automated solutions for the production of personalized medicine, today announced the appointment of Jamie Campbell as its new Chair of the Board. This strategic personnel decision further strengthens CurifyLabs’ position as the company continues its growth in Europe and expands into the North American market.
Mr. Campbell has extensive experience in the biopharma industry. He has held several leadership positions in healthcare and pharmaceutical companies, including at Swiss companies Roche and Novartis. He also founded Tulkita Technologies in Toronto, a digital transformation and innovation consultancy, and served as Chief Executive Officer of Nordic Healthcare Group, a leading expert in complex healthcare and social care challenges.
“CurifyLabs is shaping the future of personalized medicine with its pioneering solution ensuring all patients receive the best possible treatment,” Campbell. “By treating people as individuals and utilizing the best available technology, we not only conserve resources but also improve healthcare outcomes. This benefits patients, pharmacists, and society as a whole. I’m thrilled to join the CurifyLabs team as chairman to help continue its rapid growth and success.”
CurifyLabs offers automated solutions for the production of personalized medicine in hospitals and pharmacies. CurifyLabs’ solution, Pharma Kit, combines innovative printable pharmaceutical inks with automated dosing technology and quality control, making the production of personalized medicine easier, faster and more cost-effective for pharmacists.
With a presence across Europe, CurifyLabs serves leading pharmacies and hospitals, including Charité Hospital, Helios Clinics and Heidelberg University Hospital in Germany, Lausanne University Hospital in Switzerland and Delpech Pharmacie in France. The company is on a strong growth path and continues to expand its presence in Europe and penetrate the US market.
“We’re thrilled to welcome Jamie as our new Chair. His extensive experience in health technology and the pharmaceutical industry provides valuable insights for improving healthcare outcomes. Additionally, Jamie’s strong entrepreneurial background and comprehensive understanding of the North American markets uniquely position us for successful entry into a new market,” says Charlotta Topelius, co-founder and CEO of CurifyLabs.
Subscribe to our Newsletter
3DPResso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.
